Literature DB >> 6580498

Carcinogenicity of potassium bromate administered orally to F344 rats.

Y Kurokawa, Y Hayashi, A Maekawa, M Takahashi, T Kokubo, S Odashima.   

Abstract

The carcinogenicity of potassium bromate, a food additive and a neutralizer in permanent waving, was tested by adding it to the drinking water of F344 rats for 110 weeks. Groups of 53 males and 53 females, each, were given solutions of 500 or 250 ppm of potassium bromate or distilled water. A concentration of 500 ppm markedly inhibited an increase of body weight of male rats. The mean survival time was shortest for males given 500 ppm (88.1 +/- 18.1 wk); the survival times of other groups were 101-104 weeks. The percentage survival in week 104 was relatively high in all groups, and it was 77.4% for males and 66.0% for females in the control group. High incidences of renal cell tumors (in males and females given 500 or 250 ppm) and mesotheliomas of the peritoneum (in males given 500 ppm) were observed. The incidences of these tumors in test groups were significantly higher than those in controls (P less than .001). It was concluded that, when orally administered under the conditions of this experiment, potassium bromate was carcinogenic to F344 rats.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6580498

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  14 in total

1.  Toxicity and carcinogenicity of the water disinfection byproduct, dibromoacetic acid, in rats and mice.

Authors:  Ronald L Melnick; Abraham Nyska; Paul M Foster; Joseph H Roycroft; Grace E Kissling
Journal:  Toxicology       Date:  2006-12-08       Impact factor: 4.221

2.  New aspects in deriving health-based guidance values for bromate in swimming pool water.

Authors:  C Röhl; M Batke; G Damm; A Freyberger; T Gebel; U Gundert-Remy; J G Hengstler; A Mangerich; A Matthiessen; F Partosch; T Schupp; K M Wollin; H Foth
Journal:  Arch Toxicol       Date:  2022-04-06       Impact factor: 6.168

3.  Environmental exposure, chlorinated drinking water, and bladder cancer.

Authors:  Peter J Goebell; Cristina M Villanueva; Albert W Rettenmeier; Herbert Rübben; Manolis Kogevinas
Journal:  World J Urol       Date:  2003-12-20       Impact factor: 4.226

4.  [The causes of urinary bladder cancer and possibilities of prevention].

Authors:  K Golka; A W Rettenmeier; P J Goebell
Journal:  Urologe A       Date:  2006-03       Impact factor: 0.639

5.  Induction of lung tumors and peritoneal mesotheliomas in F344 rats given intragastric N-propyl-N-nitrosourea and histochemical, immunohistochemical, and ultrastructural characteristics of induced mesotheliomas.

Authors:  T Ogiu; H Fukami; A Maekawa
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

Review 6.  Drinking water disinfection byproducts: review and approach to toxicity evaluation.

Authors:  G A Boorman
Journal:  Environ Health Perspect       Date:  1999-02       Impact factor: 9.031

Review 7.  Toxicity and carcinogenicity of potassium bromate--a new renal carcinogen.

Authors:  Y Kurokawa; A Maekawa; M Takahashi; Y Hayashi
Journal:  Environ Health Perspect       Date:  1990-07       Impact factor: 9.031

8.  Balancing the risks and benefits of drinking water disinfection: disability adjusted life-years on the scale.

Authors:  A H Havelaar; A E De Hollander; P F Teunis; E G Evers; H J Van Kranen; J F Versteegh; J E Van Koten; W Slob
Journal:  Environ Health Perspect       Date:  2000-04       Impact factor: 9.031

9.  Kidney toxicogenomics of chronic potassium bromate exposure in f344 male rats.

Authors:  David R Geter; William O Ward; Geremy W Knapp; Anthony B Deangelo; Jessica A Rubis; Russell D Owen; James W Allen; Don A Delker
Journal:  Transl Oncogenomics       Date:  2006-11-23

10.  Long-term in vivo carcinogenicity tests of potassium bromate, sodium hypochlorite, and sodium chlorite conducted in Japan.

Authors:  Y Kurokawa; S Takayama; Y Konishi; Y Hiasa; S Asahina; M Takahashi; A Maekawa; Y Hayashi
Journal:  Environ Health Perspect       Date:  1986-11       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.